R Packages for ADaM in Clinical Research: Supporting Analysis Dataset Development and Regulatory Submission
- IDDCR Global Team
- 17 hours ago
- 9 min read
Introduction
In clinical research, statistical analysis plays a critical role in evaluating the safety, efficacy, and overall benefit-risk profile of a medical product. However, statistical analysis can only be reliable when the underlying analysis datasets are well-structured, traceable, and aligned with regulatory expectations.
This is where ADaM — Analysis Data Model — becomes highly important.
ADaM is a CDISC standard used to create analysis-ready datasets for clinical trial statistical analysis and regulatory submission. While SDTM focuses on organizing tabulation data collected during a clinical trial, ADaM focuses on preparing datasets that directly support statistical analysis, tables, listings, figures, and clinical study reports.
With the increasing use of R in clinical programming, several R packages are now available to support ADaM dataset development. Among these, the admiral family of packages is one of the most important open-source R-based solutions for ADaM programming.
What is ADaM?
ADaM stands for Analysis Data Model. It defines dataset and metadata standards that support the efficient generation, replication, and review of clinical trial statistical analyses.
According to CDISC, ADaM supports two major objectives:
Efficient generation, replication, and review of clinical trial statistical analyses
Traceability among analysis results, analysis data, and data represented in SDTM
In simple terms, ADaM provides a structured way to convert standardized clinical trial data into analysis-ready datasets. These datasets are then used by statistical programmers, biostatisticians, medical writers, clinical reviewers, and regulatory authorities.
Why ADaM is Important in Clinical Research
ADaM is not just a programming standard. It is a key framework that supports transparency, reproducibility, and regulatory review.
1. Supports Statistical Analysis
ADaM datasets are designed specifically for analysis. They contain derived variables, analysis flags, baseline values, change from baseline, treatment-emergent indicators, visit windows, parameter-level information, and other analysis-ready components.
This helps statistical programmers generate tables, listings, and figures more efficiently.
2. Provides Traceability
One of the most important features of ADaM is traceability. ADaM helps reviewers understand how analysis results were derived from source data and SDTM datasets.
Traceability allows reviewers to follow the path from:
SDTM data → ADaM dataset → Statistical output → Clinical study report
This is essential for regulatory review, audit readiness, and scientific transparency.
3. Improves Reproducibility
ADaM makes it easier to reproduce statistical analyses because datasets are structured according to standard rules. When ADaM datasets are properly created, another programmer or reviewer can understand the analysis logic more clearly.
4. Supports Regulatory Submission
ADaM is one of the required standards for clinical trial data submission to the FDA in the United States and PMDA in Japan.
For regulatory submissions, sponsors are expected to submit analysis datasets, metadata, Define-XML, analysis results metadata where applicable, and supporting documentation. ADaM plays a central role in this submission package.
5. Connects Clinical Data and Statistical Reporting
ADaM acts as the bridge between SDTM and final statistical outputs. It transforms standardized tabulation data into analysis-ready datasets that support clinical interpretation and decision-making.
ADaM in the Clinical Data Flow
In a typical clinical trial workflow, ADaM is created after SDTM datasets are prepared and validated.
A simplified clinical data flow looks like this:
Raw Clinical Data
Data collected from EDC, labs, ePRO/eCOA, safety systems, and external vendors.
SDTM Datasets
Raw data is standardized into SDTM domains such as DM, AE, LB, VS, EX, CM, MH, and DS.
ADaM Datasets
SDTM data is transformed into analysis-ready datasets such as ADSL, ADAE, ADLB, ADVS, ADTTE, and other analysis datasets.
Tables, Listings, and Figures
Statistical outputs are generated from ADaM datasets.
Clinical Study Report and Submission
Outputs and datasets are used for clinical study reporting and regulatory review.
Common ADaM Datasets
ADaM datasets vary depending on the study design, therapeutic area, and analysis requirements. However, some datasets are commonly used across many clinical trials.
1. ADSL — Subject-Level Analysis Dataset
ADSL is one of the most important ADaM datasets. It contains one record per subject and includes key subject-level variables such as treatment group, demographic information, population flags, baseline characteristics, randomization information, and study completion status.
ADSL is often used as the foundation for many other ADaM datasets.
2. ADAE — Adverse Event Analysis Dataset
ADAE is used for safety analysis related to adverse events. It may include treatment-emergent adverse event flags, severity, seriousness, relationship to study drug, MedDRA coding variables, and analysis flags.
ADAE supports safety tables such as:
Overall summary of adverse events
Treatment-emergent adverse events
Serious adverse events
Adverse events by system organ class and preferred term
Adverse events leading to discontinuation
3. ADLB — Laboratory Analysis Dataset
ADLB is used for laboratory data analysis. It may include baseline values, post-baseline values, change from baseline, shift categories, abnormality flags, and visit-based analysis variables.
ADLB supports lab summary tables, shift tables, and abnormal laboratory value listings.
4. ADVS — Vital Signs Analysis Dataset
ADVS is used for vital signs analysis, including parameters such as systolic blood pressure, diastolic blood pressure, pulse rate, respiratory rate, temperature, height, weight, and BMI.
5. ADTTE — Time-to-Event Analysis Dataset
ADTTE is used for time-to-event analysis. It is commonly used in oncology and other therapeutic areas where endpoints such as overall survival, progression-free survival, time to treatment failure, or time to response are analyzed.
6. BDS — Basic Data Structure
Many ADaM datasets follow the Basic Data Structure. BDS is useful for repeated measures, parameter-based analysis, and longitudinal data. Examples include lab data, vital signs, ECG data, and efficacy endpoints.
Role of R in ADaM Dataset Development
R is increasingly being used in clinical programming because it supports reproducible workflows, transparent code, automation, statistical analysis, and high-quality reporting.
For ADaM development, R can support:
Reading SDTM datasets
Applying analysis derivations
Creating subject-level and parameter-level datasets
Deriving baseline and change from baseline
Creating population flags
Creating treatment-emergent flags
Supporting time-to-event derivations
Generating analysis-ready datasets
Performing quality checks
Supporting output generation
The availability of specialized R packages has made ADaM development more structured and reusable.
The Admiral Family of R Packages for ADaM
The recommended R packages for ADaM development belong to the admiral family of packages. These packages provide a modular framework for generating ADaM datasets using R functions.
The admiral family includes a core package for common analysis needs and several therapeutic area-specific extension packages.
1. admiral
admiral stands for ADaM in R Asset Library. It is the core R package designed to support ADaM dataset development.
The package provides reusable functions that help programmers create ADaM datasets in a consistent and traceable way. Instead of writing every derivation from scratch, programmers can use standardized functions for common ADaM tasks.
Key Uses of admiral
admiral can support:
Creation of ADSL and BDS-style datasets
Derivation of population flags
Derivation of treatment variables
Baseline derivations
Change from baseline calculations
Date and time derivations
Visit and period derivations
Parameter-level dataset development
Traceability from SDTM to ADaM
Reusable and modular ADaM programming
Why admiral is Important
admiral helps clinical programmers build ADaM datasets in a more efficient and standardized way. It reduces repeated programming effort and improves consistency across studies.
For organizations, this can support:
Faster ADaM development
Improved code reuse
Better quality control
Easier review of derivation logic
More consistent programming standards
Better training for new clinical programmers
2. admiralonco — Oncology
admiralonco is an extension package designed for oncology studies.
Oncology trials often require complex endpoints and specialized analysis datasets. These may include tumor response, progression-free survival, overall survival, duration of response, time to response, disease control rate, and other oncology-specific endpoints.
Potential Use Areas
admiralonco can support ADaM programming for:
Oncology efficacy endpoints
Tumor response analysis
Time-to-event endpoints
RECIST-related derivations
Progression and response datasets
Oncology-specific analysis workflows
This package is useful for programmers working on cancer clinical trials where endpoint derivations are more complex than standard safety datasets.
3. admiralophtha — Ophthalmology
admiralophtha is an extension package designed for ophthalmology studies.
Ophthalmology trials often involve eye-specific data structures and endpoints. These may include visual acuity, intraocular pressure, retinal measurements, eye laterality, and disease-specific assessments.
Potential Use Areas
admiralophtha can support:
Eye-level analysis
Subject-level and eye-level traceability
Ophthalmology-specific efficacy endpoints
Visual function analysis
Eye-specific baseline and change calculations
This package is useful for studies where one or both eyes may contribute to analysis, and where standard subject-level structures may not be sufficient.
4. admiralvaccine — Vaccines
admiralvaccine is an extension package designed for vaccine clinical trials.
Vaccine studies often include immunogenicity endpoints, reactogenicity data, solicited adverse events, unsolicited adverse events, seroconversion, antibody titers, and immune response summaries.
Potential Use Areas
admiralvaccine can support:
Immunogenicity analysis
Antibody titer endpoints
Seroconversion analysis
Vaccine response analysis
Solicited event analysis
Vaccine-specific safety and efficacy datasets
This package is useful for vaccine studies where analysis requirements differ from traditional drug trials.
5. admiralpeds — Pediatrics
admiralpeds is an extension package designed for pediatric clinical trials.
Pediatric studies may require age-specific derivations, growth-related endpoints, weight-based dosing, developmental assessments, and pediatric-specific safety considerations.
Potential Use Areas
admiralpeds can support:
Pediatric-specific analysis variables
Age group derivations
Growth and development endpoints
Weight-based dosing analysis
Pediatric safety analysis
Child and adolescent study workflows
This package is useful for studies involving neonates, infants, children, and adolescents.
6. admiralmetabolic — Metabolism
admiralmetabolic is an extension package designed for metabolic disease studies.
Metabolic studies may involve endpoints related to glucose, insulin, HbA1c, lipid profiles, body weight, BMI, metabolic markers, and cardiovascular risk factors.
Potential Use Areas
admiralmetabolic can support:
Diabetes-related endpoints
HbA1c analysis
Glucose and insulin parameters
Lipid profile analysis
Weight and BMI endpoints
Metabolic syndrome-related analysis
This package is useful for studies in diabetes, obesity, endocrinology, and metabolic disorders.
7. admiralneuro — Neuroscience
admiralneuro is an extension package designed for neuroscience studies.
Neuroscience trials often include complex clinical scales, cognitive assessments, neurological scores, functional outcomes, psychiatric assessments, and disease-specific endpoints.
Potential Use Areas
admiralneuro can support:
Neurological assessment data
Cognitive and functional scale analysis
Disease-specific scoring systems
Repeated assessment endpoints
Neuroscience efficacy datasets
CNS-related clinical trial workflows
This package is useful for studies in neurology, psychiatry, neurodegenerative disorders, and central nervous system conditions.
How These R Packages Support ADaM Development
The admiral family of packages helps clinical programming teams move from manual, repetitive programming toward reusable and standardized ADaM workflows.
1. Modular Programming
The packages provide reusable functions for common derivations. This helps programmers build datasets step by step in a structured manner.
2. Consistency Across Studies
Using standard functions helps maintain consistency across multiple studies, therapeutic areas, and programming teams.
3. Better Traceability
ADaM requires traceability from analysis results back to SDTM data. These packages help support traceable derivation workflows.
4. Improved Efficiency
Programmers can reduce repetitive code and focus more on study-specific logic, review, and quality control.
5. Training and Knowledge Transfer
For students and new clinical programmers, these packages provide a practical way to learn ADaM concepts through hands-on R programming.
ADaM Skills Required for Clinical Programmers
Professionals working with ADaM should understand both the standard and the programming workflow.
Important skills include:
Understanding SDTM and ADaM relationship
Knowledge of ADSL and BDS structures
Ability to read SAP and define analysis requirements
Derivation of population flags
Baseline and change from baseline derivations
Treatment-emergent flag derivations
Visit windowing and analysis visit derivations
Time-to-event endpoint derivations
Dataset validation and QC
Metadata and Define-XML awareness
Ability to generate TLFs from ADaM datasets
Understanding regulatory submission expectations
Example ADaM Workflow Using R
A typical ADaM workflow using R may include the following steps:
Import SDTM datasets
Read datasets such as DM, AE, LB, VS, EX, DS, and others.
Review SAP and specifications
Understand analysis populations, endpoints, visits, baseline rules, and derivation logic.
Create ADSL
Derive subject-level variables, treatment groups, population flags, dates, and baseline characteristics.
Create BDS datasets
Develop datasets such as ADLB, ADVS, ADEG, or efficacy datasets.
Create safety datasets
Develop ADAE and related safety analysis datasets.
Create efficacy datasets
Develop endpoint-specific datasets based on the therapeutic area.
Validate datasets
Perform independent QC, compare outputs, review metadata, and check traceability.
Generate TLFs
Use ADaM datasets to produce statistical tables, listings, and figures.
Prepare submission package
Support Define-XML, reviewer guides, analysis dataset documentation, and regulatory submission files.
Why ADaM and R Packages Matter for the Future
The clinical research industry is moving toward automation, reusable programming, metadata-driven workflows, and open-source statistical computing. ADaM remains central to this transformation because it provides the analysis-ready structure required for reliable statistical reporting.
R packages such as admiral, admiralonco, admiralophtha, admiralvaccine, admiralpeds, admiralmetabolic, and admiralneuro help bring standardization and efficiency to ADaM development.
As more organizations adopt R for clinical programming, professionals who understand both ADaM standards and R-based workflows will have a strong career advantage.
Career Relevance of ADaM Knowledge
ADaM knowledge is valuable for several roles in the clinical research industry, including:
Clinical SAS Programmer
R Clinical Programmer
Statistical Programmer
Biostatistician
Clinical Data Scientist
ADaM Programmer
Regulatory Submission Programmer
Clinical Data Standards Specialist
Clinical Trial Data Analyst
TLF Programmer
For students and working professionals, learning ADaM with R can improve job readiness and help them understand how clinical trial data moves from collection to analysis and submission.
Conclusion
ADaM is a critical CDISC standard that supports efficient statistical analysis, reproducibility, traceability, and regulatory review. It connects SDTM datasets with final analysis outputs and plays a major role in clinical study reporting and submission.
The admiral family of R packages provides a practical and modern way to develop ADaM datasets using reusable functions and therapeutic area-specific extensions. The core admiral package supports common ADaM programming needs, while packages such as admiralonco, admiralophtha, admiralvaccine, admiralpeds, admiralmetabolic, and admiralneuro support specialized clinical trial requirements.
For clinical programmers, data scientists, biostatisticians, and students, learning ADaM along with R-based package workflows is an important step toward building industry-ready skills in clinical data analysis and regulatory reporting.
Comments